Patients

Patients

One person out of five will suffer from an autoimmune disease in their lifetime. The Landos team is working diligently with that patient in mind. For us, this is personal.

We know you are ready for a solution to your autoimmune disease that is lasting. It needs to take care of the current symptoms that make every day life difficult while also giving you hope for a healthy future—a future that does not involve surgery or serious side effects.

For someone with an autoimmune disease the current treatment options themselves are often worse than the disease and become part of the litany of negative side effects. Injections and infusions are disruptive to every day living and are an uncomfortable way to receive medication. We are striving to one day make them unnecessary. Our drive is to develop treatment options that are convenient and comfortable to take—that is why we focus solely on oral therapies.

We have developed a first-in-class, oral therapy for Inflammatory Bowel Disease (IBD) and its two clinical manifestations: Crohn’s disease and ulcerative colitis. It has shown remarkable preclinical results and is entering clinical trials in 2018. Our team is poised to offer patients with IBD and other autoimmune disease a better way.

You are ready for a treatment that supports every day living and a healthy and happy future and we are working to make it a reality. We will continue to push forward, at an accelerated pace, knowing that people like you are suffering from autoimmune diseases and are eager for a treatment that works for you, your life, and your future.